Heart Attack :: New blood thinner may work without bleeding risk
Clinical trial of new blood thinner shows promise of significantly reducing the risk of heart attack and death with no statistical increase in major and minor bleeding events.
Clinical trial of new blood thinner shows promise of significantly reducing the risk of heart attack and death with no statistical increase in major and minor bleeding events.
Severe heart attacks are often treated with non-surgical procedures that open narrowed or blocked arteries of the heart using stents (percutaneous coronary intervention, or PCI).
Mayo Clinic has designed a new system to speed critical care to acute heart attack patients that dramatically reduces the time that elapses before patients undergo a life-saving procedure — by as much as 45 percent in some cases.
An international study using ultrasound technology has found that the most potent cholesterol-lowering drug is also effective at halting early changes in the blood vessels that can lead to atherosclerosis.
Although the use of stents to treat coronary artery disease has soared during the past decade thanks to novel equipment and new implant techniques, clinical data has recently raised concerns around the safety of drug-eluting stents (DES) and their risk of post-procedure complications.
Genetics and family history play a large role in a person?s risk for heart disease, but factors in diet, lifestyle and the environment are also thought to influence susceptibility to the disease.
The use of medicines to fight cardiovascular disease has been a primary focus of research in this area for the past several decades, as combinations of interventions and medicinal therapy have gradually begun to increase long-term survival rates.
Geneticists have discovered a new gene that may put individuals at higher risk of developing cardiovascular disease.
Many young and middle-aged people of Chinese ancestry told they are at risk of going blind from glaucoma may be getting incorrect information, say researchers at the Stanford University School of Medicine.
Patients with arterial disease have relatively high rates of experiencing a cardiovascular event (such as heart attack, stroke or cardiovascular death) within one year, and these increase with the number of arterial locations afflicted, according to a large, international study in the March 21 issue of JAMA.